N@N

WILMINGTON, Del.--([ BUSINESS WIRE ])--[ Rigrodsky & Long, P.A. ] announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired the stock of The Cooper Companies, Inc. (aCoopera or the aCompanya) (NYSE: [ COO ]) between March 4, 2011 and November 15, 2011, inclusive (the aClass Perioda) alleging violations of the Securities Exchange Act of 1934 (the aComplainta). The case is entitled Wallen v. The Cooper Companies, Inc., Case No. C-11-6214-WHA (N.D. Cal.).

If you wish to view a copy of the Complaint, discuss this action, or have any questions concerning this notice or your rights or interests, please contact [ Timothy J. MacFall, Esquire ] or [ Noah R. Wortman, Case Development Director ] of Rigrodsky & Long, P.A., 919 North Market Street, Suite 980 Wilmington, Delaware, 19801 at (888) 969-4242, by e-mail to [ info@rigrodskylong.com ], or at: [ http://www.rigrodskylong.com/news/cooper-companies-inc ].

Cooper, through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and womenas healthcare markets worldwide.

The Complaint asserts that Cooper and several of its key executives violated the federal securities laws through the issuance of materially false and misleading public statements, as well as the failure to disclose material information, concerning quality control issues and manufacturing process defects in its CooperVision contact lens operations, as well as the business prospects of the Company during the Class Period.

In late 2009, the Company moved its contact lens manufacturing facilities from Norfolk, Virginia to new manufacturing plants in Puerto Rico and the United Kingdom to cut costs. Throughout the Class Period, defendants reassured investors that the quality of its product offerings remained high. As a consequence of the cost savings achieved by the move, among other things, defendants raised Cooperas earnings guidance three times during the Class Period. This, in turn, caused the Companyas stock price to climb above $84 per share by September 2011.

In August 2011, the Company announced a alimited voluntarya recall of its Avaira Toric line of contact lenses which were manufactured in Puerto Rico. Defendants reported that the limited recall was caused by aa small numbera of users that had complained of atemporary hazy vision.a

In October 2011, however, the United States Food and Drug Administration (the aFDAa) issued a Class I warning, calling for the Company to issue full notice to the public of the reasons for the recall of nearly 780,000 of its Avaira Tonic lenses.

On November 15, 2011, the Company finally disclosed that was expanding the recall to include nearly five million Avaira Sphere lenses that had already shipped. Cooper also disclosed that it reserved more than $23 million for recall related liabilities. As a consequence, the price of Cooperas common stock price fell from a closing price of $64.95 per share on November 14, 2011, the day prior to the disclosure of the expanded recall, to a close of $56.64 per share on November 15, 2011, the day of the announcement on extremely heavy trading volume.

If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2012. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class memberas claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

[ Rigrodsky & Long, P.A. ], with offices in Wilmington, Delaware and Garden City, New York, [ regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation ], including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.